WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (164)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malberg, J. E.
Right arrow Articles by Seiden, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malberg, J. E.
Right arrow Articles by Seiden, L. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*3,4-METHYLENEDIOXYMETHAMPHETAMINE
*DOPAMINE
*SODIUM CHLORIDE
Medline Plus Health Information
*Club Drugs

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 1, 1998, 18(13):5086-5094

Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

Jessica E. Malberg and Lewis S. Seiden

University of Chicago, Department of Pharmacological and Physiological Sciences, Chicago, Illinois 60637

The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA) is a drug of abuse and has been shown to be neurotoxic to 5-HT terminals in many species. MDMA-engendered neurotoxicity has been shown to be affected by both ambient temperature and core body temperature. We now report that small (2°C) changes in ambient temperature produce changes in core temperature in MDMA-treated rats, but the same changes in ambient temperature do not affect core temperature of saline-treated animals. Furthermore, increases in core temperature of MDMA-treated animals increase neurotoxicity. Rats were given MDMA (20 or 40 mg/kg) or saline and placed in an ambient temperature of 20, 22, 24, 26, 28, or 30°C using a novel temperature measurement apparatus that controls ambient temperature ±0.5°C. Two weeks after MDMA treatment, the rats were killed, and regional 5-HT and 5-hydroxyindole acetic acid levels were analyzed as a measure of neurotoxicity. Rats treated with MDMA at 20 and 22°C showed a hypothermic core temperature response. Treatment with MDMA at 28 and 30°C produced a hyperthermic response. At ambient temperatures of 20-24°C, neurotoxicity was not observed in the frontal cortex, somatosensory cortex, hippocampus, or striatum. At ambient temperatures of 26-30°C, neurotoxicity was seen and correlated with core temperature in all regions examined. These data indicate that ambient temperature has a significant affect on MDMA neurotoxicity, core temperature, and thermoregulation in rats. This finding has implications on both the temperature dependence of the mechanism of MDMA neurotoxicity and human use because fatal hyperthermia is associated with MDMA use in humans.

Key words: MDMA; amphetamine; core body temperature; ambient temperature; neurotoxicity; 5-HT; thermoregulation


Copyright © 1998 Society for Neuroscience  0270-6474/98/18135086-09$05.00/0


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. Mueller, J. Yuan, A. Felim, A. Neudorffer, F. T. Peters, H. H. Maurer, U. D. McCann, M. Largeron, and G. A. Ricaurte
Further Studies on the Role of Metabolites in ({+/-})-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
Drug Metab. Dispos., October 1, 2009; 37(10): 2079 - 2086.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. Green, C. Marsden, and K. Fone
MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt
J Psychopharmacol, November 1, 2008; 22(8): 929 - 931.
[PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. E. Rusyniak, M. V. Zaretskaia, D. V. Zaretsky, and J. A. DiMicco
3,4-Methylenedioxymethamphetamine- and 8-Hydroxy-2-di-n-propylamino-tetralin-Induced Hypothermia: Role and Location of 5-Hydroxytryptamine 1A Receptors
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 477 - 487.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. L. Banks, J. E. Sprague, D. F. Kisor, P. W. Czoty, D. E. Nichols, and M. A. Nader
Ambient Temperature Effects on 3,4-Methylenedioxymethamphetamine-Induced Thermodysregulation and Pharmacokinetics in Male Monkeys
Drug Metab. Dispos., October 1, 2007; 35(10): 1840 - 1845.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Alves, T. Summavielle, C. J. Alves, J. Gomes-da-Silva, J. C. Barata, E. Fernandes, M. de Lourdes Bastos, M. A. Tavares, and F. Carvalho
Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria
J. Neurosci., September 19, 2007; 27(38): 10203 - 10210.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
B. Sessa
Is there a case for MDMA-assisted psychotherapy in the UK?
J Psychopharmacol, March 1, 2007; 21(2): 220 - 224.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. J. Piper, H. L. Vu, M. G. Safain, A. J. Oliver, and J. S. Meyer
Repeated Adolescent 3,4-Methylenedioxymethamphetamine (MDMA) Exposure in Rats Attenuates the Effects of a Subsequent Challenge with MDMA or a 5-Hydroxytryptamine1A Receptor Agonist
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 838 - 849.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress
J Psychopharmacol, March 1, 2006; 20(2): 147 - 163.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
N. Easton and C. A. Marsden
Ecstasy: Are animal data consistent between species and can they translate to humans?
J Psychopharmacol, March 1, 2006; 20(2): 194 - 210.
[Abstract] [PDF]


Home page
Br. J. PsychiatryHome page
D. Arnone, F. Schifano, and B. Sessa
Psychedelics in psychiatry * Author's reply:
The British Journal of Psychiatry, January 1, 2006; 188(1): 88 - 89.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. C. Jones, C. Duvauchelle, A. Ikegami, C. M. Olsen, S. S. Lau, R. de la Torre, and T. J. Monks
Serotonergic Neurotoxic Metabolites of Ecstasy Identified in Rat Brain
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 422 - 431.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. S. Darvesh, B. K. Yamamoto, and G. A. Gudelsky
Evidence for the Involvement of Nitric Oxide in 3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletion in the Rat Brain
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 694 - 701.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
J Psychopharmacol, January 1, 2005; 19(1): 71 - 83.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
V. Sanchez, E. O'shea, K. S. Saadat, J. M. Elliott, M. I. Colado, and A. R. Green
Effect of Repeated ('Binge') Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones
J Psychopharmacol, September 1, 2004; 18(3): 412 - 416.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
A. R. Green, A. O. Mechan, J. M. Elliott, E. O'Shea, and M. I. Colado
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
Pharmacol. Rev., September 1, 2003; 55(3): 463 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. E. Sprague, M. L. Banks, V. J. Cook, and E. M. Mills
Hypothalamic-Pituitary-Thyroid Axis and Sympathetic Nervous System Involvement in Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy)
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 159 - 166.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. C. Nicholas and L. S. Seiden
Ambient Temperature Influences Core Body Temperature Response in Rat Lines Bred for Differences in Sensitivity to 8-Hydroxy-dipropylaminotetralin
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 368 - 374.
[Abstract] [Full Text]


Home page
ScienceHome page
G. A. Ricaurte, J. Yuan, G. Hatzidimitriou, B. J. Cord, and U. D. McCann
Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")
Science, September 27, 2002; 297(5590): 2260 - 2263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
L. Reneman, C. B. L. M. Majoie, H. Flick, and G. J. den Heeten
Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 231 - 237.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. P. Pedersen and W. W. Blessing
Cutaneous Vasoconstriction Contributes to Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) in Conscious Rabbits
J. Neurosci., November 1, 2001; 21(21): 8648 - 8654.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
H. Kalant
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
Can. Med. Assoc. J., October 1, 2001; 165(7): 917 - 928.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. J. Lester, M. Baggott, S. Welm, N. B. Schiller, R. T. Jones, E. Foster, and J. Mendelson
Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial
Ann Intern Med, December 19, 2000; 133(12): 969 - 973.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Xie, U. D. McCann, S. Kim, J. Yuan, and G. A. Ricaurte
Effect of Temperature on Dopamine Transporter Function and Intracellular Accumulation of Methamphetamine: Implications for Methamphetamine-Induced Dopaminergic Neurotoxicity
J. Neurosci., October 15, 2000; 20(20): 7838 - 7845.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. E. Sabol, J. B. Richards, and K. Yung
The Effects of High-Dose Methamphetamine in the Aging Rat: Differential Reinforcement of Low-Rate 72-s Schedule Behavior and Neurochemistry
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 850 - 863.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. M. Allan, L. C. Parker, B. Collins, R. Davies, G. N. Luheshi, and N. J. Rothwell
Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat
PNAS, May 9, 2000; 97(10): 5580 - 5585.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-